Šalis: Airija
kalba: anglų
Šaltinis: HPRA (Health Products Regulatory Authority)
LOSARTAN POTASSIUM
Clear Pharmacy
C09CA01
LOSARTAN POTASSIUM
100 Milligram
Film Coated Tablet
Product subject to prescription which may be renewed (B)
Angiotensin II antagonists, plain
Authorised
2010-10-01
PACKAGE LEAFLET: INFORMATION FOR THE USER COZAAR® 50MG FILM-COATED TABLETS COZAAR® 100MG FILM-COATED TABLETS LOSARTAN POTASSIUM READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor, pharmacist, or nurse. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What COZAAR is and what it is used for 2. What you need to know before you take COZAAR 3. How to take COZAAR 4. Possible side effects 5. How to store COZAAR 6. Contents of the pack and other information 1. WHAT COZAAR IS AND WHAT IT IS USED FOR Losartan (COZAAR) belongs to a group of medicines known as angiotensin-II receptor antagonists. Angiotensin-II is a substance produced in the body which binds to receptors in blood vessels, causing them to tighten. This results in an increase in blood pressure. Losartan prevents the binding of angiotensin-II to these receptors, causing the blood vessels to relax which in turn lowers the blood pressure. Losartan slows the decrease of kidney function in patients with high blood pressure and type 2 diabetes. COZAAR is used to treat patients with high blood pressure (hypertension) in adults and in children and adolescents 6 – 18 years of age to protect the kidney in hypertensive type 2 diabe Perskaitykite visą dokumentą
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Cozaar 100mg Film-coated Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each Cozaar 100mg tablet contains 100mg of losartan potassium. Each Cozaar 100mg tablet contains lactose monohydrate. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated Tablet. _Product imported from the UK and Poland:_ White, teardrop-shaped film-coated tablets marked ‘960’ on one side and plain on the other. 4 CLINICAL PARTICULARS As per PA 1286/004/003 5 PHARMACOLOGICAL PROPERTIES As per PA 1286/004/003 6 PHARMACEUTICAL PARTICULARS 6.1 LIST OF EXCIPIENTS Microcrystalline cellulose (E460) Lactose monohydrate Pregelatinized maize starch Magnesium stearate (E572) Hyprolose (E463) Hypromellose (E464) Contains potassium 8.48mg (0.216mEq) Also contains Carnauba wax (E903), Titanium dioxide (E171) 6.2 INCOMPATIBILITIES Not applicable. HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 15/10/2014_ _CRN 2132370_ _page number: 1_ 6.3 SHELF LIFE The shelf-life expiry date of this product is the date shown on the blister and outer carton of the product on the market in the country of origin. 6.4 SPECIAL PRECAUTIONS FOR STORAGE Store in the original package in order to protect from light and moisture. 6.5 NATURE AND CONTENTS OF CONTAINER Blisters in an overlabelled outer carton containing 28 tablets. 6.6 SPECIAL PRECAUTIONS FOR DISPOSAL No special requirements. 7 PARALLEL PRODUCT AUTHORISATION HOLDER Clear Pharmacy 157-173 Roden Street Belfast BT12 5QA United Kingdom 8 PARALLEL PRODUCT AUTHORISATION NUMBER PPA 1596/3/2 9 DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 1st October 2010 10 DATE OF REVISION O Perskaitykite visą dokumentą